Clínica Universidad de Navarra - Hospital
Pamplona, Navarre 31008
1 studies enrolling now · 1 studies all time
What they study most
Advanced Solid Tumor
Studies at this site
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
— Recruiting now